Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) — Cash Flow Reinvestment Rate
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) has a Cash Flow Reinvestment Rate of 0.19x as of December 2025, reinvesting CN¥159.70 Million (capex CN¥152.89 Million plus investments CN¥-6.81 Million) from operating cash flow of CN¥837.18 Million. See 301408 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A across 5 annual periods. For the full cash flow conversion analysis, see Anhui Huaren Health Pharmaceutical Co. L (301408) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (2021–2025)
Year-by-year capital reinvestment analysis for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A. See Anhui Huaren Health Pharmaceutical Co. L free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | CN¥159.70 Million | CN¥837.18 Million | CN¥152.89 Million | ▼ -32.4% |
| 2024 | 0.28x | CN¥161.29 Million | CN¥571.76 Million | CN¥160.89 Million | ▼ -87.6% |
| 2023 | 2.27x | CN¥298.08 Million | CN¥131.37 Million | CN¥216.31 Million | ▲ +225.7% |
| 2022 | 0.70x | CN¥121.08 Million | CN¥173.84 Million | CN¥104.77 Million | ▲ +89.8% |
| 2021 | 0.37x | CN¥51.68 Million | CN¥140.82 Million | CN¥33.91 Million | — |